These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 29166610)

  • 1. CISD2 Haploinsufficiency Disrupts Calcium Homeostasis, Causes Nonalcoholic Fatty Liver Disease, and Promotes Hepatocellular Carcinoma.
    Shen ZQ; Chen YF; Chen JR; Jou YS; Wu PC; Kao CH; Wang CH; Huang YL; Chen CF; Huang TS; Shyu YC; Tsai SF; Kao LS; Tsai TF
    Cell Rep; 2017 Nov; 21(8):2198-2211. PubMed ID: 29166610
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Shen ZQ; Huang YL; Tsai TF
    Mol Cell Oncol; 2018; 5(3):e1441627. PubMed ID: 30250893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NCOA5 Haploinsufficiency in Myeloid-Lineage Cells Sufficiently Causes Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma.
    Zhang Y; Luo Y; Liu X; Kiupel M; Li A; Wang H; Mi QS; Xiao H
    Cell Mol Gastroenterol Hepatol; 2024; 17(1):1-27. PubMed ID: 37734594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deranged hepatocyte intracellular Ca
    Ali ES; Rychkov GY; Barritt GJ
    Cell Calcium; 2019 Sep; 82():102057. PubMed ID: 31401389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCL2-CISD2: An ER complex at the nexus of autophagy and calcium homeostasis?
    Chang NC; Nguyen M; Shore GC
    Autophagy; 2012 May; 8(5):856-7. PubMed ID: 22617439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisd2 Protects the Liver from Oxidative Stress and Ameliorates Western Diet-Induced Nonalcoholic Fatty Liver Disease.
    Huang YL; Shen ZQ; Huang CH; Teng YC; Lin CH; Tsai TF
    Antioxidants (Basel); 2021 Apr; 10(4):. PubMed ID: 33916843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
    Kanda T; Goto T; Hirotsu Y; Masuzaki R; Moriyama M; Omata M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32102237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CISD2 maintains cellular homeostasis.
    Shen ZQ; Huang YL; Teng YC; Wang TW; Kao CH; Yeh CH; Tsai TF
    Biochim Biophys Acta Mol Cell Res; 2021 Apr; 1868(4):118954. PubMed ID: 33422617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisd2 modulates the differentiation and functioning of adipocytes by regulating intracellular Ca2+ homeostasis.
    Wang CH; Chen YF; Wu CY; Wu PC; Huang YL; Kao CH; Lin CH; Kao LS; Tsai TF; Wei YH
    Hum Mol Genet; 2014 Sep; 23(18):4770-85. PubMed ID: 24833725
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of animal models to investigate nonalcoholic steatohepatitis-associated hepatocellular carcinoma.
    Wu J
    Oncotarget; 2016 Jul; 7(27):42762-42776. PubMed ID: 27072576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bioinformatics analysis reveals novel core genes associated with nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Feng G; Li XP; Niu CY; Liu ML; Yan QQ; Fan LP; Li Y; Zhang KL; Gao J; Qian MR; He N; Mi M
    Gene; 2020 Jun; 742():144549. PubMed ID: 32184169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.
    Tiniakos DG; Maurício J; Reeves HL
    Adv Exp Med Biol; 2018; 1032():55-69. PubMed ID: 30362090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
    Zoller H; Tilg H
    Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CISD2 associated with proliferation indicates negative prognosis in patients with hepatocellular carcinoma.
    Chen B; Shen S; Wu J; Hua Y; Kuang M; Li S; Peng B
    Int J Clin Exp Pathol; 2015; 8(10):13725-38. PubMed ID: 26722601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
    Takahashi Y; Fukusato T
    World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.
    Charrez B; Qiao L; Hebbard L
    World J Gastroenterol; 2016 Feb; 22(8):2494-502. PubMed ID: 26937137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse models for investigating the underlying mechanisms of nonalcoholic steatohepatitis-derived hepatocellular carcinoma.
    Takakura K; Oikawa T; Tomita Y; Mizuno Y; Nakano M; Saeki C; Torisu Y; Saruta M
    World J Gastroenterol; 2018 May; 24(18):1989-1994. PubMed ID: 29760542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TERT promoter mutations and chromosome 8p loss are characteristic of nonalcoholic fatty liver disease-related hepatocellular carcinoma.
    Ki Kim S; Ueda Y; Hatano E; Kakiuchi N; Takeda H; Goto T; Shimizu T; Yoshida K; Ikura Y; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Uemoto S; Chiba T; Ogawa S; Marusawa H
    Int J Cancer; 2016 Dec; 139(11):2512-8. PubMed ID: 27511114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. JCAD Promotes Progression of Nonalcoholic Steatohepatitis to Liver Cancer by Inhibiting LATS2 Kinase Activity.
    Ye J; Li TS; Xu G; Zhao YM; Zhang NP; Fan J; Wu J
    Cancer Res; 2017 Oct; 77(19):5287-5300. PubMed ID: 28775168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.